Publications by authors named "Maria Carmen Rodenas"

Unlabelled: Recently, our group identified serine-protease hepsin from primary tumor as a biomarker of metastasis and thrombosis in patients with localized colorectal cancer. We described hepsin promotes invasion and thrombin generation of colorectal cancer cells in vitro and in vivo and identified venetoclax as a hepsin inhibitor that suppresses these effects. Now, we aspire to identify additional hepsin inhibitors, aiming to broaden the therapeutic choices for targeted intervention in colorectal cancer.

View Article and Find Full Text PDF

Hepsin is a type II transmembrane serine protease and its expression has been linked to greater tumorigenicity and worse prognosis in different tumors. Recently, our group demonstrated that high hepsin levels from primary tumor were associated with a higher risk of metastasis and thrombosis in localized colorectal cancer patients. This study aims to explore the molecular role of hepsin in colorectal cancer.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the protease furin, which plays a role in various diseases, including cancer and infections, aiming to find new compounds that can inhibit its activity.
  • Researchers conducted virtual screening to identify potential inhibitors, leading to the selection of Zeaxanthin and Kukoamine A, which showed promise in blocking furin.
  • The selected compounds, along with existing inhibitor CMK, demonstrated a dose-dependent inhibitory effect on furin and increased CMK's effectiveness in preventing S protein cleavage, crucial for SARS-CoV-2 infection.
View Article and Find Full Text PDF

Antithrombin, the main physiological inhibitor of the coagulation cascade, exerts anti-tumor effects on glioblastoma multiforme cells. Antithrombin has different conformations: native, heparin-activated, prelatent, latent, and cleaved. The prelatent form has an intermediate affinity between latent and native antithrombin, although it is the most antiangiogenic form.

View Article and Find Full Text PDF

N-linked glycosylation is a crucial post-translational modification involved in protein folding, function, and clearance. N-linked glycosylation is also used therapeutically to enhance the half-lives of many proteins. Antithrombin, a serpin with four potential N-glycosylation sites, plays a pivotal role in hemostasis, wherein its deficiency significantly increases thrombotic risk.

View Article and Find Full Text PDF